Seizures, Affective Disorders and Anticonvulsant Drugs

**Seizures, Affective Disorders, and Anticonvulsant Drugs: A Comprehensive Exploration** Delve into the complex interplay between epilepsy, mood disorders, and the therapeutic efficacy of anticonvulsant medications with this in-depth examination, "Seizures, Affective Disorders, and Anticonvulsant Drugs." Edited by Michael Trimble and Bettina Schmitz, this authoritative hardcover volume offers a comprehensive overview of a critical area in neurological and psychiatric research. Published by Clarius Press in 2002, this book is a valuable resource for clinicians, researchers, and advanced students seeking a deeper understanding of the neuropsychiatric comorbidities associated with epilepsy and the evolving landscape of its pharmacological management. This meticulously compiled work bridges the disciplines of neurology and psychiatry, addressing the frequent co-occurrence of affective disorders, such as depression and anxiety, in patients with epilepsy. It meticulously explores the neurobiological underpinnings of these conditions, examining how seizure activity can impact mood regulation and how mood disorders themselves may influence seizure frequency and severity. The editors have brought together leading experts to provide insights into the diagnostic challenges, clinical presentations, and the underlying pathophysiological mechanisms that link these two distinct yet often intertwined conditions. Furthermore, "Seizures, Affective Disorders, and Anticonvulsant Drugs" offers a detailed analysis of the diverse range of anticonvulsant drugs currently available and their multifaceted effects. Beyond their primary role in seizure control, the book investigates their impact on affective states, highlighting both the potential for mood stabilization and the risk of treatment-emergent mood disturbances. Readers will gain valuable knowledge on the pharmacokinetics, pharmacodynamics, and clinical applications of various anticonvulsant agents, with a particular focus on their efficacy and tolerability in patients presenting with co-existing affective symptoms. The book likely covers established medications as well as emerging treatments, providing a snapshot of the field as of its publication date. Drawing upon cutting-edge research and clinical experience, this publication serves as an essential reference for navigating the intricate therapeutic decisions involved in managing patients with both epilepsy and mood disorders. It addresses crucial questions surrounding drug selection, polypharmacy, and the optimization of treatment strategies to improve both seizure control and overall quality of life for individuals affected by these challenging conditions. The insights provided are crucial for anyone involved in the care of patients with neurological and psychiatric sequelae. This particular copy, presented in a sturdy hardcover format without a dust jacket (featuring printed boards), is in very good condition. Acquired from the offices of a world-leading nuclear medicine research establishment, it reflects a history of academic rigor. While the spine ends and board corners show some minor bumping and scuffing, and there are a couple of faint marks on the page block, the internal pages remain sound, clear, and eminently readable, ready to impart its wealth of knowledge to its next custodian.